...relaxer tolperisone from Sanochemia Pharmazeutika AG (Xetra:SAC). The drug is marketed in Europe and Asia. Tolperisone...
...Longitude's Josh Richardson joined Neurana's board. Neurana Pharmaceuticals Inc., San Diego, Calif. Mark Zipkin Agileo, Viveo, tolperisone (AV650) H.I.G...

...relaxer tolperisone from Sanochemia Pharmazeutika AG (Xetra:SAC). The drug is marketed in Europe and Asia. Tolperisone...
...Dan Becker, H.I.G.'s Alex Zisson and Longitude's Josh Richardson joined Neurana's board. Mark Zipkin Agileo, Viveo, tolperisone (AV650) H.I.G...

...Sanochemia granted newco Katama exclusive rights in North America to develop and commercialize spasticity product tolperisone...
...Sanochemia, which will manufacture tolperisone for Katama, is eligible for milestones, plus royalties. Sanochemia markets tolperisone...

...Inc. (San Diego, Calif.) exclusive rights in North America to develop and commercialize spasticity product tolperisone...
...Sanochemia, which will manufacture tolperisone for Katama, is eligible for milestones, plus royalties. Sanochemia markets tolperisone...

...states the agency concluded that the benefits did not outweigh the risks for Meditop's Myderison tolperisone...
...Republic, Germany, Lithuania, Poland and Slovakia. Meditop Pharmaceutical Co. Ltd. , Pilisborosjeno, Hungary Product: Myderison tolperisone...

...Lampert wrote to Avigen shareholders. Deal in the wings On Oct. 21, Avigen's tolperisone ( AV650...

...October and returned to Sanochemia Pharmazeutika AG (Xetra:SAC, Vienna, Austria) its rights to tolperisone ( AV650...

...clinical trials and product manufactured on a commercial scale Avigen (NASDAQ:AVGN) Discontinues development of tolperisone (AV650...

...The company restructured in October and returned to Sanochemia (Xetra:SAC) its rights to tolperisone ( AV650...

...per share cash value. On Oct. 21, the company had announced that its tolperisone ( AV650...
...of his current stake in the past seven weeks. In the run up to the AV650...